Our results also suggested that Asian people with TTF-1-positive nonsq NSCLC, especially Japanese patients, may benefit from a regimen with PEM, and a combination with ICIs may lead to further prolonged survival. Here, RHOH is linked to non-small cell lung carcinoma.